A 3D linear solvation energy model to quantify the affinity of flavonoid derivatives toward P-glycoprotein

被引:38
作者
Boccard, Julien [1 ,4 ]
Bajot, Fania [1 ]
Di Pietro, Attilio [3 ]
Rudaz, Serge [4 ]
Boumendjel, Ahcene [2 ]
Nicolle, Edwige [2 ]
Carrupt, Pierre-Alain [1 ]
机构
[1] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Unite pharmacochim, CH-1211 Geneva 4, Switzerland
[2] Univ Grenoble, CNRS, Dept Pharmacochim Mol, Fac Pharm,UMR 5063, F-38041 Grenoble 9, France
[3] Univ Lyon 1, CNRS, Inst Biol & Chim Prot, UMR 5086,IFR Biosci Gerland Lyon Sud 128, F-69367 Lyon 07, France
[4] Univ Lausanne, Univ Geneva, Sch Pharmaceut Sci, Lab Chim Analyt Pharmaceut, CH-1211 Geneva 4, Switzerland
关键词
Flavonoid derivatives; P-glycoprotein inhibitors; 3D QSAR; Molecular Interaction Fields; LSER; VolSurf descriptors; Pgp/ABCB1; MULTIDRUG-RESISTANCE; CRYSTAL-STRUCTURE; BINDING; TRANSPORTERS; ATP; PERMEABILITY; MODULATION; INHIBITOR; FAMILY; DOMAIN;
D O I
10.1016/j.ejps.2008.09.009
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
P-glycoprotein (Pgp/ABCB1) both accounts for multidrug resistance (MDR) in chemotherapy and contributes to reduce oral bioavailability and brain distribution of drugs. Flavonoids, reported as potent Pgp inhibitors, are able to bind to the cytosolic ATP-binding site and a vicinal hydrophobic pocket. In order to explore the interaction forces governing the affinity of flavonoids towards Pgp, the 3D quantitative structure-activity relationship (QSAR) approach was used to analyze a set of flavonoid derivatives. The variation of affinity towards Pgp was investigated by VolSurf descriptors of Molecular Interaction Fields (MIFs) related to hydrophobic interaction forces, polarizability, and hydrogen-bonding capacity. The 3D linear solvation energy VolSurf model developed here identifies shape parameters and hydrophobicity as the major physicochemical parameters responsible for the affinity of flavonoid derivatives towards Pgp and hydrogen-bonding capacities as minor modulators of this activity. Furthermore, this predictive model (q(2) of 0.71) was also validated by use of an external set of 10 flavones. (c) 2008 Elsevier B.V All rights reserved.
引用
收藏
页码:254 / 264
页数:11
相关论文
共 42 条
[21]   Mini review on molecular modeling of P-glycoprotein (Pgp) [J].
Ha, Sookhee N. ;
Hochman, Jerome ;
Sheridan, Robert P. .
CURRENT TOPICS IN MEDICINAL CHEMISTRY, 2007, 7 (15) :1525-1529
[22]  
Halgren TA, 1999, J COMPUT CHEM, V20, P730, DOI 10.1002/(SICI)1096-987X(199905)20:7<730::AID-JCC8>3.0.CO
[23]  
2-T
[24]   SURFACE GLYCOPROTEIN MODULATING DRUG PERMEABILITY IN CHINESE-HAMSTER OVARY CELL MUTANTS [J].
JULIANO, RL ;
LING, V .
BIOCHIMICA ET BIOPHYSICA ACTA, 1976, 455 (01) :152-162
[25]  
Kane SE, 1996, ADV DRUG RES, V28, P181
[26]  
Kems E. H., 2008, DRUG LIKE PROPERTIES
[27]   The influence of drug-like concepts on decision-making in medicinal chemistry [J].
Leeson, Paul D. ;
Springthorpe, Brian .
NATURE REVIEWS DRUG DISCOVERY, 2007, 6 (11) :881-890
[28]   Crystal structure of a human cyclin-dependent kinase 6 complex with a flavonol inhibitor, fisetin [J].
Lu, HS ;
Chang, DJ ;
Baratte, B ;
Meijer, L ;
Schulze-Gahmen, U .
JOURNAL OF MEDICINAL CHEMISTRY, 2005, 48 (03) :737-743
[29]  
Martin YC, 1998, QSAR THR DIM QUAN ST, V3, P3
[30]  
Nilsson J, 1997, J CHEMOMETR, V11, P511